Applied Common Stock Shares Outstanding vs Intangible Assets Analysis
APDN Stock | USD 0.15 0.01 6.25% |
Applied DNA financial indicator trend analysis is way more than just evaluating Applied DNA Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Applied DNA Sciences is a good investment. Please check the relationship between Applied DNA Common Stock Shares Outstanding and its Intangible Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Common Stock Shares Outstanding vs Intangible Assets
Common Stock Shares Outstanding vs Intangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Applied DNA Sciences Common Stock Shares Outstanding account and Intangible Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Applied DNA's Common Stock Shares Outstanding and Intangible Assets is 0.76. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Applied DNA Sciences, assuming nothing else is changed. The correlation between historical values of Applied DNA's Common Stock Shares Outstanding and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Applied DNA Sciences are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Common Stock Shares Outstanding i.e., Applied DNA's Common Stock Shares Outstanding and Intangible Assets go up and down completely randomly.
Correlation Coefficient | 0.76 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Most indicators from Applied DNA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied DNA Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. As of the 30th of November 2024, Selling General Administrative is likely to drop to about 10 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 10.3 M
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 18.2M | 13.4M | 15.4M | 16.1M | Research Development | 3.9M | 3.7M | 4.3M | 4.5M |
Applied DNA fundamental ratios Correlations
Click cells to compare fundamentals
Applied DNA Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied DNA fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Current Liabilities | 4.3M | 3.3M | 4.2M | 2.8M | 3.3M | 3.9M | |
Total Stockholder Equity | 5.7M | 11.1M | 12.9M | 5.0M | 5.7M | 6.0M | |
Retained Earnings | (269.8M) | (284.1M) | (292.5M) | (302.4M) | (272.2M) | (258.6M) | |
Accounts Payable | 1.3M | 1.4M | 1.7M | 1.1M | 1.2M | 892.3K | |
Common Stock Shares Outstanding | 196.0K | 345.9K | 448.4K | 653.8K | 751.8K | 789.4K | |
Non Current Liabilities Total | 1.4M | 31.5K | 5.2M | 5.9M | 6.8M | 7.2M | |
Other Stockholder Equity | 275.5M | 295.2M | 305.4M | 307.4M | 353.5M | 371.2M | |
Total Liab | 5.6M | 3.3M | 9.4M | 8.8M | 10.1M | 10.6M | |
Common Stock | 5.1K | 7.5K | 12.9K | 13.7K | 12.3K | 11.7K | |
Other Current Liab | 676.4K | 1.6M | 1.9M | 1.2M | 1.1M | 1.1M | |
Total Assets | 11.3M | 14.4M | 22.3M | 13.7M | 15.7M | 16.5M | |
Net Debt | (5.4M) | (6.6M) | (15.2M) | (5.9M) | (5.3M) | (5.1M) | |
Cash | 7.8M | 6.6M | 15.2M | 7.2M | 8.2M | 8.6M | |
Cash And Short Term Investments | 7.8M | 6.6M | 15.2M | 7.2M | 8.2M | 8.6M | |
Liabilities And Stockholders Equity | 11.3M | 14.4M | 22.3M | 13.7M | 15.7M | 16.5M | |
Total Current Assets | 9.1M | 11.3M | 19.9M | 8.1M | 9.3M | 5.0M | |
Non Current Assets Total | 2.3M | 3.1M | 2.3M | 5.5M | 6.4M | 6.7M | |
Intangible Assets | 864.2K | 734.8K | 605.3K | 2.7M | 2.4M | 2.6M | |
Property Plant And Equipment Net | 1.3M | 3.0M | 2.2M | 2.1M | 2.4M | 2.5M | |
Current Deferred Revenue | 511.0K | 281K | 563.6K | 76.4K | 68.8K | 65.4K | |
Non Currrent Assets Other | 95.1K | 95.0K | 99.0K | 750K | 862.5K | 905.6K | |
Property Plant And Equipment Gross | 1.3M | 3.8M | 4.3M | 5.5M | 6.3M | 6.6M | |
Net Receivables | 194.3K | 2.8M | 3.1M | 255.5K | 293.8K | 279.1K | |
Other Current Assets | 1.2M | 1.1M | 2.1M | 389.2K | 447.6K | 509.6K | |
Net Tangible Assets | (1.9M) | 4.8M | 11.1M | 12.9M | 14.8M | 15.6M | |
Property Plant Equipment | 226.2K | 1.3M | 3.0M | 2.2M | 2.6M | 2.7M | |
Other Assets | 172.0K | 95.1K | 95.0K | 99.0K | 89.1K | 84.6K | |
Inventory | 497.4K | 1.4M | 602.2K | 330.0K | 379.5K | 347.2K | |
Other Liab | 622.0K | 848.3K | 31.5K | 5.2M | 5.9M | 6.2M |
Pair Trading with Applied DNA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.Moving against Applied Stock
0.87 | GLW | Corning Incorporated | PairCorr |
0.87 | JBL | Jabil Circuit | PairCorr |
0.81 | ZBRA | Zebra Technologies | PairCorr |
0.75 | FLEX | Flex | PairCorr |
0.75 | MYNA | Mynaric AG ADR | PairCorr |
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.50) | Revenue Per Share 2.202 | Quarterly Revenue Growth (0.73) | Return On Assets (0.57) | Return On Equity (0.76) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.